©2025 RXinsider | RXinsider Market Intelligence Group | 2025
ASHP advocates for
states to regulate
training and education
for pharmacists and
support staff engaging
in telepharmacy.
Source: ASHP
Areas of Concern Regarding Telepharmacy
The following are noted as “Areas of Concern Regarding
Telepharmacy” according to ASHP’s Statement on Telehealth
Pharmacy Practice.
DEA should not be more
restrictive than necessary
regarding telepharmacy
because it could impact
pharmacy services in
locations that would not have
pharmacy services without
telepharmacy.
ASHP members feel that
pharmacists registered
with DEA should be
allowed to manage
care with regards to
controlled substances in
a similar manner allowed
by their state scope of
practice as is any other
recognized provider.
DEA needs to be
transparent about
the elements of
telepharmacy
practice over which
it has regulatory
authority.
The DEA’s current
definition of
telepharmacy
needs to be
expanded.